#Sugiholdings

Allocating 5,082,000 new shares to GIC Private Limited via third-party allotment, with an approximate net proceeds of 16,008,439,600 yen after miscellaneous expenses. Payment date: July 27, 2026. Purpose: strengthen financial base for the new medium-term management plan and build strategic long-term partnerships.

In the first quarter of fiscal year 2026, Sugi Pharmacy's same-store sales increased by 6.4%, and total store sales grew by 9.3%. The drugstore business increased by 6.6%, and the dispensing business by 5.8%. Nine new stores were opened, and five stores closed, bringing the total number of stores to 2,343.

Sugi Holdings has announced its financial results for the May 2026 fiscal year. Specific figures such as revenue and net income are unknown, but an overview of performance and shareholder relations are provided.

In March 2026, Sugi Pharmacy's existing store sales increased by 5.7% YoY, with total store sales rising 8.5%. The drugstore segment saw a 3.2% increase at existing stores, while the dispensing pharmacy segment grew 12.0%. In March, 12 new stores opened, and 3 stores closed.

For the fiscal year ending February 2026, consolidated net sales amounted to 1,010,336 million yen (15.1% increase YoY), operating income was 48,568 million yen (14.1% increase YoY), and net income attributable to owners of parent was 44,982 million yen (75.1% increase YoY). A stock split is scheduled for September 1, 2026.

Sugi Holdings has additionally acquired 2,182 shares of Seki Yakuhin Co., Ltd., increasing its ownership ratio from 49.0% to 51.0%, with plans to consolidate it as a subsidiary on September 1, 2026.

On the record date of August 31, 2026, a stock split of 1 share into 2 shares will be implemented, doubling the number of outstanding shares from approximately 190 million to about 380 million shares. The dividend forecast for the fiscal year ending February 2027 is effectively unchanged at 35 yen per year on a pre-split basis. The shareholder benefits...

For February 2026, Sugi Pharmacy's same-store sales increased 5.4% year-on-year, and total store sales rose 7.8%. With 8 new store openings and 4 closures, the total number of stores reached 2,321 locations.

At the Board of Directors meeting held on January 26, 2026, director candidates and auditor candidates to be submitted to the 44th Annual General Meeting of Shareholders were determined. Mr. Masahiro Nakamura is scheduled to be appointed as a new auditor.

Sugi Holdings Co., Ltd. will change its executive officer structure effective March 1, 2026, appointing multiple executive officers including three new members.

For December 2025, Sugi Pharmacy existing store sales increased by 0.7% YoY; total store sales increased by 2.3%. The drugstore segment’s existing store sales declined 2.5%, while the dispensing pharmacy segment grew 9.7%. In December, 9 new stores opened, 3 stores closed, bringing the total store count to 2,309.

For the third quarter of the fiscal year ending February 2026, net sales totaled 750.127 billion yen (18.2% YoY increase), operating income was 34.137 billion yen (18.7% YoY increase), and net income attributable to owners of parent was 35.667 billion yen (87.1% YoY increase).